The MTPConnect Podcast

Mar 06 2025 189 ep. 34 mins 33
The MTPConnect Podcast artwork

The MTPConnect Podcast Series connects with the people and the issues behind Australia’s growing medical technologies, biotechnologies and pharmaceuticals sector.

  Science  Health & Fitness  Business
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Ready to Export Your Medtech to Europe?

Mar 06 2025 20 mins  
Dive into another episode coming to you from MTPConnect’s Development Workshop Series held recently in Sydney for 52 start-up organisations from around Australia. The 2-day program was a terrific opportunity for companies participating in our Accelerator programs to get ‘investor ready’. Exportia Australia’s Christelle Damiens, an entrepreneur and award-winning author, shar

Unlocking Intrinsic Value to Get Investor Ready

Feb 18 2025 22 mins  
This episode is coming to you from MTPConnect’s Development Workshop Series held in Sydney for 52 start-up organisations from around Australia. The 2-day program was a terrific opportunity for companies participating in our Accelerator programs to get ‘investor ready’. Advisory firm Intrinsika’s workshop, ‘Finding Your Intrinsic Value’, focused on how to reframe a compa

Exploring the Australian Stroke and Heart Accelerator’s High Potential Research Portfolio

Feb 12 2025 34 mins  
The Australian Stroke and Heart Research Accelerator, established through MTPConnect’s Targeted Translation Research Accelerator for cardiovascular disease and diabetes on behalf the Medical Research Future Fund, is a research centre with a bold vision to deliver new health outcomes in coronary artery disease, heart failure and stroke. Through clinical impact and entrepreneurship

Heart and Soul: Dr Daniel Timms on Creating the First Successful Total Artificial Heart

Dec 10 2024 36 mins  
We meet Dr Daniel Timms, the Australian biomechanical engineer behind BiVACOR who has dedicated his life to developing a titanium Total Artificial Heart (TAH) to restore the lives of people with end-stage heart failure, a disease that impacted his own family. It’s a 25-year quest that has taken him from a PhD at QUT, developing the device with his father in his parent’s kitchen

How the UK’s Subscription-Style Model is Improving Access to Much-Needed Antibiotics

Nov 27 2024 17 mins  
As World Antimicrobial Resistance Awareness Week (WAAW) kicked off around the globe, the Australian Antimicrobial Resistance Network (AAMRNet) was meeting in Canberra to explore how Australia can better support the development of and access to new antimicrobial technologies. Key clinicians, researchers, industry and government representatives gathered to discuss how a subscription-

New Approaches to Fighting Superbugs – Backing New Treatments and Better Access for Patients with Drug Resistant Infections

Nov 17 2024 31 mins  
It’s World Antimicrobial Resistance Awareness Week (WAAW) and the theme is "Educate. Advocate. Act now". It’s a yearly global campaign, raising awareness of antimicrobial resistance (AMR) and promoting ways to reduce the spread of drug-resistant infections. To mark the occasion, MTPConnect’s Andrew Bowskill, Co-chair of the Australian Antimicrobial Resistance Network, AAMRNet

Medtech Matters: Australia’s medtech delegation hits North America

Oct 30 2024 33 mins  
As thousands in the medical technology sector headed to Toronto, Canada for The MedTech 2024 Conference, MTPConnect was making sure that the 18 companies and organisations joining the Australian delegation were given opportunities to showcase their capabilities and make valuable US and international connections with a stopover in the medtech hub of Minnesota, before hitting Toronto

TTRA Information Session: Funding call for Drugs and Devices Addressing Cardiovascular Disease and Complications of Diabetes

Oct 13 2024 68 mins  
In July 2024, MTPConnect was selected to deliver a new $28.5 million investment for Drugs and Devices, which builds on the legacy of the inaugural TTRA program. The objective of TTRA Drugs and Devices is to accelerate development and commercialisation of promising drugs and medical devices into products that can reduce the burden of cardiovascular disease and complications of diabe

Omico: Using Genomics to Accelerate Access to Next Generation Cancer Treatments

Sep 23 2024 39 mins  
Omico is leading Australia’s largest cancer genomics initiative –giving 23,000 Australians nationwide with advanced or incurable cancers, access to genomic profiling to detect unique genetic variations in their tumours to identify potential matches to new targeted treatments options. It is opening up new treatment pathways, extending lives and attracting more international tria

Biocom California's Mission to Connect Down Under

Sep 05 2024 40 mins  
Biocom California is the US state’s advocate for the life sciences industry with a network of over 1700 members. With offices located in San Diego, Los Angeles, San Francisco Bay Area, Sacramento, Washington, D.C, and Tokyo the group is focused on building international collaborations and networks to bring new medicines to patients. MTPConnect recently signed an MoU with Biocom C